XML 79 R65.htm IDEA: XBRL DOCUMENT v3.26.1
FINANCIAL INSTRUMENTS - Schedule of Investments Without Readily Determinable Fair Value (Details) - USD ($)
$ in Thousands
6 Months Ended 12 Months Ended
Jun. 30, 2026
Dec. 31, 2025
Feb. 28, 2025
Investments Without Readily Determinable Fair Value Roll Forward [Abstract]      
Beginning balance $ 10,250 $ 27,775  
Purchases   1,250  
Impairments   (11,000)  
Realized gain of prior investments   5,863  
Settled investments   (13,599)  
Foreign currency adjustments   (39)  
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease) 0    
Ending balance 10,250 10,250  
GQ Bio Acquisition | GQ Bio Acquisition      
Investments Without Readily Determinable Fair Value Roll Forward [Abstract]      
Percentage of voting interests acquired     81.00%
Equity Investments      
Investments Without Readily Determinable Fair Value Roll Forward [Abstract]      
Beginning balance 7,750 15,877  
Purchases   0  
Impairments   (4,000)  
Realized gain of prior investments 4,200 4,189  
Settled investments   (8,277)  
Foreign currency adjustments   (39)  
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease) 0    
Ending balance 7,750 7,750  
Convertible Notes Receivable      
Investments Without Readily Determinable Fair Value Roll Forward [Abstract]      
Beginning balance 2,500 11,898  
Purchases   1,250  
Impairments   (7,000)  
Realized gain of prior investments 1,700 1,674  
Settled investments   (5,322)  
Foreign currency adjustments   0  
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease) 0    
Ending balance $ 2,500 $ 2,500